These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Holzer P, Holzer-Petsche U. Pharmacol Ther; 1997; 73(3):219-63. PubMed ID: 9175156 [Abstract] [Full Text] [Related]
5. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII. Broccardo M, Improta G, Tabacco A. Eur J Pharmacol; 1999 Jul 02; 376(1-2):67-71. PubMed ID: 10440091 [Abstract] [Full Text] [Related]
9. Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease. Holzer P. Digestion; 1998 Jul 02; 59(4):269-83. PubMed ID: 9693197 [Abstract] [Full Text] [Related]
10. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists. Picard P, Regoli D, Couture R. Br J Pharmacol; 1994 May 02; 112(1):240-9. PubMed ID: 7518304 [Abstract] [Full Text] [Related]
12. Molecular recognition of tachykinin receptor selective agonists: insights from structural studies. Ganjiwale A, Cowsik SM. Mini Rev Med Chem; 2013 Dec 02; 13(14):2036-46. PubMed ID: 23937231 [Abstract] [Full Text] [Related]
13. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat. Wagner U, Fehmann H, Bredenbröker D, Klüber D, Lange A, Wichert P. Neuropeptides; 1999 Feb 02; 33(1):55-61. PubMed ID: 10657472 [Abstract] [Full Text] [Related]